[HTML][HTML] HPV-FRAME: A consensus statement and quality framework for modelled evaluations of HPV-related cancer control
K Canfell, JJ Kim, S Kulasingam, J Berkhof… - Papillomavirus …, 2019 - Elsevier
Intense research activity in HPV modelling over this decade has prompted the development
of additional guidelines to those for general modelling. A specific framework is required to …
of additional guidelines to those for general modelling. A specific framework is required to …
Costs and cost-effectiveness of 9-valent human papillomavirus (HPV) vaccination in two East African countries
S Kiatpongsan, JJ Kim - PLoS One, 2014 - journals.plos.org
Background Current prophylactic vaccines against human papillomavirus (HPV) target two
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …
[HTML][HTML] Impact of HPV vaccination: Achievements and future challenges
JML Brotherton - Papillomavirus research, 2019 - ncbi.nlm.nih.gov
The size and scope of the impacts of HPV vaccines to date are somewhat extraordinary,
given their apparent limitations and the public health challenges faced at the outset in …
given their apparent limitations and the public health challenges faced at the outset in …
Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study
Background The quadrivalent and bivalent human papillomavirus (HPV) vaccines are now
licensed in several countries. We compared the cost-effectiveness of the HPV vaccines to …
licensed in several countries. We compared the cost-effectiveness of the HPV vaccines to …
Modeling preventative strategies against human papillomavirus-related disease in developed countries
K Canfell, H Chesson, SL Kulasingam, J Berkhof… - Vaccine, 2012 - Elsevier
Over the last 5 years, prophylactic vaccination against human papillomavirus (HPV) in pre-
adolescent females has been introduced in most developed countries, supported by …
adolescent females has been introduced in most developed countries, supported by …
Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of …
RP Insinga, EJ Dasbach, EH Elbasha - BMC infectious diseases, 2009 - Springer
Background Natural history models of human papillomavirus (HPV) infection and disease
have been used in a number of policy evaluations of technologies to prevent and screen for …
have been used in a number of policy evaluations of technologies to prevent and screen for …
Modeling cervical cancer prevention in developed countries
Cytology-based screening has reduced cervical cancer mortality in countries able to
implement, sustain and financially support organized programs that achieve broad …
implement, sustain and financially support organized programs that achieve broad …
Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
Abstract Background The World Health Organization (WHO) recommends that the cost
effectiveness of introducing human papillomavirus (HPV) vaccination is considered before …
effectiveness of introducing human papillomavirus (HPV) vaccination is considered before …
Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
Background Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative …
highest burden of HPV is not universal, partly because of the absence of quantitative …
Cost-effectiveness analyses of human papillomavirus vaccination
With a human papillomavirus (HPV) vaccine soon to become available for widespread use,
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …
several studies have modelled the cost-effectiveness of vaccination. These pioneer studies …